Glucagon‐like peptide‐1 receptor agonist semaglutide reduces atrial fibrillation incidence: A systematic review and meta‐analysis
Article in European Journal of Clinical Investigation (July 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in European Journal of Clinical Investigation (July 2024)
Article in npj Cardiovascular Health (March 2024)
Article in Nutrition Metabolism and Cardiovascular Diseases (September 2023)